Citations
263 citation(s) found for "Chanan‐Khan, Asher".
Phase II Trial of Elotuzumab with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) in the Post-Daratumumab Progression Setting
LaPlant, Betsy, Alegria, Victoria R., Elliott, Jamie, Sher, Taimur , Paulus, Aneel , Chapin, Dustin, Heslop, Keisha, Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Roy, Vivek
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4450-4451
Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis
Gardner, Lindsay B., Moustafa, Mohamad Alhaj, Sher, Taimur , Rasheed, Ahsan , Warsame, Rahma , Larsen, Jeremy T. , Kourelis, Taxiarchis , Kapoor, Prashant , Chanan‐Khan, Asher , Parrondo, Ricardo D , Roy, Vivek , Gonsalves, Wilson I. , Fonseca, Rafaël , Ailawadhi, Sikander
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7237-7238
Time-Limited Maintenance with Ibrutinib after First-Line Therapy and the Incremental Impact on Minimal Residual Disease (MRD) for Patients with Chronic Lymphocytic Leukemia (CLL)
Paulus, Aneel , LaPlant, Betsy, Alegria, Victoria R., Zimmerman, Ashley, Chapin, Dustin, Sher, Taimur , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Roy, Vivek
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9904-9905
Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a
Chanan‐Khan, Asher , Mudenda, Boyd, Nogaieva, Larysa, Usenko, Hanna, Perekhrestenko, Tetiana , Muzhychuk, Ivan, Myasnikov, Alexander G., Maslyak, Zvenyslava, Proidakov, Andrew, Uspenskaya, Olga, Borisenkova, Elena , Marlton, Paula , Winter, Allison , Lysa, Tamila, Fu, Lei, Glass, Laura A., Ahmad, Mohammad, Карпенко, Олена, Osipov, Iurii , De, Asit K. , Paudyal, Ben, Wang, Hengbang , Winkler, Robert L. , Gabrail, Nashat , Ganju, Vinod , Константинова, Т. С. , Samoylova, Olga, Yang, Dajun , Davids, Matthew S. , Kriachok, Iryna , Ivanov, Vladimir, Kyselova, Olena , Myasnikov, Alexander, Uspenskaya, Olga, Siddiqi, Tanya , Бакиров, Б. А. , Chen, Zi , Yu, Min , Li, Mingyu , Glass, Laura, Karpenko, Olena, De, Asit, Winkler, Robert, Zhai, Yifan
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2326-2328
A Phase 1 Study of Plamotamab, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma: Recommended Dose Safety/Efficacy Update and Escalation Exposure-Response Analysis
Patel, Krish , Tilly, Hervé , Ghesquières, Hervé , Collela, Jean Marc Schiano de, Chanan‐Khan, Asher , Bouabdallah, Kamal , Long, Meixiao, Clynes, Raphael , Kanodia, Jitendra , Bao, Lei , Ding, Ying , Jin, Jianhua , Ainsworth, William B., Garcha, Raman, Kye, Steve, Patel, Krish , Riedell, Peter A. , Ahmed, Sairah , Michot, Jean‐Marie , Tessoulin, Benoit , Iyengar, Sunil , Bao, Lei, Phillips, Tycel
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9470-9472
Phase II Study of Ibrutinib in Combination with Ixazomib in Patients with Waldenström Macroglobulinemia (WM)
LaPlant, Betsy, Alegria, Victoria R., Elliott, Jamie, Zimmerman, Ashley, Heslop, Keisha, Chapin, Dustin, Sher, Taimur , Rasheed, Ahsan , Paulus, Aneel , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Roy, Vivek
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9331-9332
Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients
Pérez, Gabriela , Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto, O’Brien, Patrick, Alegria, Victoria R., Zimmerman, Ashley, Chapin, Dustin, Lanier, Stephanie, Kasik, Carly, Bradley, Schannon, Sher, Taimur , Paulus, Aneel , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Murthy, Hemant S. , Roy, Vivek
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10165-10166
Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination
Zanwar, Saurabh , Larsen, Jeremy T. , Chanan‐Khan, Asher , Hayman, Suzanne R. , Kapoor, Prashant , Kourelis, Taxiarchis , Lacy, Martha Q. , Lin, Yi , Sher, Taimur , Warsame, Rahma , Fonder, Amie , Hobbs, Miriam, Hwa, Yi L. , Kyle, Robert A. , Kumar, Shaji , Ho, Matthew , Buadi, Francis K. , Ailawadhi, Sikander , Bergsagel, P. Leif , Binder, Moritz , Dingli, David , Dispenzieri, Angela , Fonseca, Rafaël , Gertz, Morie A. , Gonsalves, Wilson I. , Go, Ronald S. , Leung, Nelson , Muchtar, Eli , Roy, Vivek , Rajkumar, S. Vincent
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10017-10019
Waldenstrom Macroglobulinemia and the Clinical Implications of Acquired Von Willebrand Syndrome
Chohan, Karan , Zanwar, Saurabh , Thompson, Carrie A. , Chanan‐Khan, Asher , Ansell, Stephen M. , Kumar, Shaji , Pruthi, Rajiv K. , Nichols, William L., Kapoor, Prashant , Abeykoon, Jithma P. , Chohan, Karan L , Go, Ronald S. , Paludo, Jonas , Ailawadhi, Sikander , Habermann, Thomas M. , Witzig, Thomas E. , Gertz, Morie A. , Sridharan, Meera
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9363-9365
Genomic Pathways Differentiating IgM-MGUS from Waldenstrom Macroglobulinemia: The Integrated microRNA and Gene Expression Landscape
Dasari, Surendra , Abeykoon, Jithma P. , Kapoor, Prashant , Reeder, Craig B. , Chanan‐Khan, Asher , Kyle, Robert A. , Novak, Anne J. , Ansell, Stephen M. , Chohan, Karan , Paludo, Jonas , Braggio, Esteban , Manske, Michelle K. , Paulus, Aneel , Ailawadhi, Sikander , Gertz, Morie A.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9242-9243